Bausch Health Americas, Inc.
Clinical trials sponsored by Bausch Health Americas, Inc., explained in plain language.
-
New drug formulation aims to prevent dangerous brain fog in liver disease patients
Disease control OngoingThis study tests whether a new version of the drug rifaximin can delay the first episode of overt hepatic encephalopathy (confusion and brain issues) in people with liver cirrhosis who have controlled fluid buildup (ascites). About 466 adults will receive either the drug or a pla…
Phase: PHASE3 • Sponsor: Bausch Health Americas, Inc. • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
New laser promises smoother skin in latest trial
Symptom relief OngoingThis study tests a next-generation Fraxel laser on 49 adults aged 21–60 with skin spots, lesions, or wrinkles around the eyes. The goal is to see if three treatments improve skin appearance and how satisfied patients are with the results. It is an early-phase, single-arm trial wi…
Phase: NA • Sponsor: Bausch Health Americas, Inc. • Aim: Symptom relief
Last updated Apr 29, 2026 15:15 UTC
-
Acne gel study: will patients stick with it?
Symptom relief OngoingThis study tracks about 200 people aged 12 and older with acne who use a prescription gel containing three active ingredients. Researchers want to see how satisfied patients are, how well they follow the treatment, and how it affects their quality of life over 20 weeks. The goal …
Sponsor: Bausch Health Americas, Inc. • Aim: Symptom relief
Last updated Apr 26, 2026 20:03 UTC
-
Psoriasis drug safety under the microscope: 3,500 patients tracked for cancer risk
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows 3,500 adults with moderate-to-severe psoriasis to see how safe brodalumab is over the long term compared to other treatments. Researchers are tracking how many people develop cancer (excluding common skin cancers) while using brodalumab versus other biologic dr…
Sponsor: Bausch Health Americas, Inc. • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:48 UTC